Patient self-injection for chronic disease treatments is on the rise. Due to the complexity of injectable treatment regimens, the disease management process and patients’ emotional responses to changes in their lives related to their disease, onboarding aids, such as reusable demonstration devices, are becoming an increasingly prevalent and vital part of the patient onboarding process.
Demonstrators replicate actual medication delivery systems without the needle or medicament and allow patients to learn how to use a specific device in order to improve familiarity, increase confidence and build adherent behaviors.
To assist pharmaceutical manufacturers during development and in preparation for launch, Noble and BD have established a collaborative development framework to support the BD UltraSafe™ passive needle guard product family, with a customizable demonstrator platform to serve manufacturers developing and launching drug delivery systems. Providing demonstrators to pharmaceutical companies to enhance their patient education programs is becoming more important.